STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

EBS (NYSE: EBS) holder files Form 144 to sell 32,848 shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

EBS reported a planned insider sale under Rule 144. A company affiliate intends to sell 32,848 shares of common stock, with an aggregate market value of $392,334.78, through Morgan Stanley Smith Barney LLC on the NYSE around 12/05/2025. The issuer has 52,519,964 shares outstanding, providing context for the size of this transaction.

The shares come from a mix of restricted stock awards granted between 2021 and 2022 and a stock option exercise for 25,748 shares paid in cash on 12/05/2025. By signing the notice, the seller represents that they are not aware of any material adverse information about EBS’s current or prospective operations that has not been publicly disclosed.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the EBS Form 144 filing disclose?

The filing discloses that an affiliate of EBS plans to sell 32,848 shares of common stock under Rule 144, using Morgan Stanley Smith Barney LLC as broker on the NYSE.

How many EBS shares are being sold and what is their market value?

The affiliate plans to sell 32,848 EBS common shares with an aggregate market value of $392,334.78 as indicated in the Form 144.

How were the EBS shares in the Form 144 acquired?

The shares were acquired through restricted stock grants in 2021 and 2022 and a stock option exercise for 25,748 shares on 12/05/2025, which was paid in cash.

How many EBS shares are outstanding according to this Form 144?

The Form 144 states that 52,519,964 EBS common shares were outstanding at the time referenced in the filing.

What representation does the EBS insider make in this Form 144?

By signing, the seller represents they do not know any material adverse information about EBS’s current or prospective operations that has not been publicly disclosed.

On which exchange will the EBS shares be sold under this Form 144?

The filing indicates the EBS common shares are expected to be sold on the NYSE through Morgan Stanley Smith Barney LLC.
Emergent Biosolutions Inc

NYSE:EBS

EBS Rankings

EBS Latest News

EBS Latest SEC Filings

EBS Stock Data

632.87M
50.95M
2.84%
70.19%
16.33%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
GAITHERSBURG